OSG vs PATH · rev $92.0M vs P/E 19, rev $1.61B
Octave Specialty Group, Inc. (OSG) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Octave Specialty Group, Inc. (OSG) is a insurance - specialty company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported OSG revenue for 2024-12-31 was $92.0M. Net income was -$20.9M. Revenue was up 79.4% from 2023-12-31 to 2024-12-31. OSG currently screens at market cap $260.2M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
OSG currently screens at market cap $260.2M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the OSG and PATH stock pages for the full models.
Not investment advice.